RNS Number : 1438R
Kropz PLC
27 February 2023
 

27 February 2023

Kropz Plc

("Kropz" or the "Company")

Drawdown On New Convertible Equity Facility

Kropz Plc (AIM: KRPZ) is pleased to confirm that it has made its fourth drawdown request under the new ZAR 550 million convertible equity facility from the Company's largest shareholder, ARC Fund ("ZAR 550 Million Equity Facility"), as announced on 14 November 2022.

The fourth drawdown is for ZAR 40 million (approximately US$ 2.2 million). ZAR 7.5 million remains available for drawdown over the term of the ZAR 550 Million Equity Facility.

The next drawdown of the ZAR 550 Million Equity Facility is expected to be made on or about 23 March 2023 in line with the terms of the ZAR 550 Million Equity Facility.

ARC Fund has the right, at any time, to convert any outstanding amount under the ZAR 550 Million Equity Facility into new ordinary shares in Kropz Plc.

 

For further information visit www.kropz.com or contact:

Kropz Plc

Via Tavistock

Louis Loubser (CEO)

+44 (0) 207 920 3150

 

 

Grant Thornton UK LLP

Nominated Adviser

Samantha Harrison

Harrison Clarke

George Grainger

Ciara Donnelly

 

+44 (0) 20 7383 5100

 


Hannam & Partners

Broker

Andrew Chubb

Ernest Bell

+44 (0) 20 7907 8500

 

 

Tavistock

Financial PR & IR (UK)

Nick Elwes

Jos Simson

Emily Moss

+44 (0) 207 920 3150

kropz@tavistock.co.uk

 

 

R&A Strategic Communications

PR (South Africa)

Charmane Russell

Marion Brower

+27 (0) 11 880 3924

charmane@rasc.co.za 

marion@rasc.co.za

 

 

About Kropz Plc

Kropz is an emerging African phosphate producer with projects in South Africa and in the Republic of Congo. The vision of the Group is to become a leading independent phosphate rock producer and to develop into an integrated, mine-to-market plant nutrient company focusing on sub-Saharan Africa.

-ENDS-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCNKOBPCBKKCBB